## Templates {data-progressive=FALSE}

### Dose-PK/Exposure
  - [PK - Single Ascending Dose](https://opensource.nibr.com/xgx/Single_Ascending_Dose_PK.html)
  - [PK - Multiple Ascending Dose](https://opensource.nibr.com/xgx/Multiple_Ascending_Dose_PK.html)
  

### Dose-PD/Efficacy/Safety
  - [PD, Dose-Response - Continuous Endpoint](https://opensource.nibr.com/xgx/Multiple_Ascending_Dose_PD_continuous.html)
  - [PD, Dose-Response - Binary Response](https://opensource.nibr.com/xgx/Multiple_Ascending_Dose_PD_binary.html)
  - [PD, Dose-Response - Ordinal](https://opensource.nibr.com/xgx/Multiple_Ascending_Dose_PD_ordinal.html)
  - [PD, Dose-Response - Count](https://opensource.nibr.com/xgx/Multiple_Ascending_Dose_PD_count.html)
  - [PD, Dose-Response - Time to Event](https://opensource.nibr.com/xgx/Multiple_Ascending_Dose_PD_time_to_event.html)
  - [PD, Oncology, RECIST - continuous, binary and categorical endpoints](https://opensource.nibr.com/xgx/Oncology_Efficacy_Plots.html)

  
### PK-PD/Efficacy/Safety
  - [PK/PD, Exposure-Response - Continuous](https://opensource.nibr.com/xgx/Multiple_Ascending_Dose_PKPD_continuous.html)
  - [PK/PD, Exposure-Response - Binary](https://opensource.nibr.com/xgx/Multiple_Ascending_Dose_PKPD_binary.html)
  - [PK/PD, Exposure-Response - Ordinal](https://opensource.nibr.com/xgx/Multiple_Ascending_Dose_PKPD_ordinal.html)
  - [PK/PD, Exposure-Response - Count](https://opensource.nibr.com/xgx/Multiple_Ascending_Dose_PKPD_count.html)
  - [PK/PD, Exposure-Response - Time to Event](https://opensource.nibr.com/xgx/Multiple_Ascending_Dose_PKPD_time_to_event.html)
  - [Safety Plots](https://opensource.nibr.com/xgx/Adverse_Events.html)
  - [QT Prolongation](https://opensource.nibr.com/xgx/QT_Prolongation.html)
